• Products
  • Insights
  • Practice Management
  • Resources
  • About Us

Domestic Equity fund

Hartford Healthcare HLS Fund   


Actions

Domestic Equity fund

Hartford Healthcare HLS Fund   
Share Class - HLS IB (HBGHX)

Effective 12/31/17, this Fund is closed to certain qualified pension and retirement plans.  For more information, please refer to the fund's statutory prospectus.

Objective

Seeks long-term capital appreciation.

Overview

A stock fund that invests exclusively in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

Portfolio Management
Senior Managing Director
Global Industry Analyst
4
YRS
MANAGING THIS FUND
17
YRS
AT WELLINGTON MANAGEMENT
19
YRS
EXPERIENCE IN THIS INDUSTRY
Managing Director
Global Industry Analyst
3
YRS
MANAGING THIS FUND
9
YRS
AT WELLINGTON MANAGEMENT
17
YRS
EXPERIENCE IN THIS INDUSTRY
Managing Director
Global Industry Analyst
2
YRS
MANAGING THIS FUND
11
YRS
AT WELLINGTON MANAGEMENT
25
YRS
EXPERIENCE IN THIS INDUSTRY

The portfolio managers are supported by the full resources of Wellington.

Performance

PERFORMANCE %
 
CUMULATIVE %
(as of 9/30/2024)
AVERAGE ANNUAL TOTAL RETURNS %
(as of 9/30/2024)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS IB 13.39 22.85 2.66 10.86 9.86 11.29
Benchmark 14.01 21.46 7.44 12.91 11.15 ---
Morningstar Health Category 10.57 21.36 -0.43 9.42 8.64 ---
 
CUMULATIVE %
(as of 9/30/2024)
AVERAGE ANNUAL TOTAL RETURNS %
(as of 9/30/2024)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS IB 13.39 22.85 2.66 10.86 9.86 11.29
Benchmark 14.01 21.46 7.44 12.91 11.15 ---
Morningstar Health Category 10.57 21.36 -0.43 9.42 8.64 ---

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. For more current performance information to the most recent month ended, please visit hartfordfunds.com.

SI = Since Inception. Fund Inception: 05/01/2000

Hartford Healthcare HLS Fund IB Share Morningstar Ratings
Morningstar Medalist RatingTM
8/31/2024

Characteristics

FUND ESSENTIALS
Inception Date 05/01/2000
Net Assets $147 million
Total Operating Expenses 1.17%
Morningstar Category Health
Lipper Classification Health/Biotechnology Funds
CUSIP 416528693
Fund Number 2056
FUND STATS
# of Holdings
102
% in Equities
99
% in Foreign Equities
16
Beta (3 year)
0.99
R Squared (3 year)
0.91
Standard Deviation
15.28%
Turnover
28%
Active Share
47%
Holdings Characteristics
FUND S&P Composite 1500 Health Care Index
Price/Earnings
28.8x 18.4x
Price/Book
5.7x 5.3x
EPS Growth Rate
22.3% 17.1%
Asset Weighted Market Cap (billions)
$231.5 $284.9
Return on Equity
20.4% 33.6%
Median Market Cap (billions)
$10.5 $7.2
Top Holdings (%)
Eli Lilly & Co. 11.47
UnitedHealth Group, Inc. 8.75
Merck & Co., Inc. 3.62
Danaher Corp. 3.55
Boston Scientific Corp. 3.27
Thermo Fisher Scientific, Inc. 2.91
Vertex Pharmaceuticals, Inc. 2.53
Stryker Corp. 2.38
HCA Healthcare, Inc. 2.17
AstraZeneca PLC 2.07
Total Portfolio % 42.72
Market Cap Distribution (%)

Market Cap Header3

Less than $2 billion 3
$2 billion - $5 billion 8
$5 billion - $10 billion 9
Greater than $10 billion 80
Not Classified 0
Subsector Exposure (%)
Biopharma Large Cap 36
Health Care Services 26
Medical Technology 24
Biopharma Mid Cap 11
Biopharma Small Cap 4
Biopharma Large Cap 37
Medical Technology 24
Health Care Services 23
Biopharma Mid Cap 13
Biopharma Small Cap 3
Based on sub-adviser's classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap. Excludes cash. May not total to 100% due to rounding.
distributions and capital gains
Distribution Date Distribution NAV ordinary income short term capital gains long term capital gains total distribution
8/23/2024 16.56 $0.0000 $0.0000 $0.1131 $0.1131
Past distributions are not indicative of future distributions.

Fund Literature


06/30/2024 - PDF (266 KB)
Current quarterly commentary from our sub-adviser, Wellington Management, which includes a performance review, attribution, statistics, and positioning and outlook for the Fund.
PDF (102 KB)
A summary of a fund's full-length prospectus that provides key information potential investors should consider before making an investment decision.
An unaudited financial report, which includes a fund's financial statements. These reports are intended for shareholders and others who have reviewed the fund's prospectus.
PDF (13 KB)
A legal document that discloses essential information about a fund, including investment objectives, risks, fees, expenses, fund manager background and other information.
An audited financial report, which includes a fund's financial statements. These reports are intended for shareholders and others who have reviewed the fund's prospectus.
PDF (13 KB)
A document that supplements the fund's prospectus with additional information about the fund including its operations and risks.
Important Risks: Investing involves risk, including the possible loss of principal. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. • Risks of focusing investments on the healthcare related sector include regulatory and legal developments, changes in funding or subsidies, patent and intellectual property considerations, intense competitive pressures, rapid technological changes, long and costly process for obtaining product approval by government agencies, potential product obsolescence, rising cost of medical products and services, and price volatility risk. • Small- and mid-cap securities can have greater risks and volatility than large-cap securities. • Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political, economic and regulatory developments. These risks may be greater, and include additional risks, for investments in emerging markets.

Hartford HLS Funds are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA. Advisory services are provided by Hartford Funds Management Company, LLC (HFMC). The Funds are sub-advised by Wellington Management Company LLP. HFMC and Wellington Management are SEC registered investment advisers. Hartford Funds refers to HFD and HFMC, which are not affiliated with any sub-adviser.

3566491